During the first wave of the global COVID-19 pandemic in 2020 reports began to emerge that some patients had persistent symptoms weeks or months following SARS-CoV-2 infection despite having laboratory recovery of acute disease.
To better understand this phenomenon, WHO met with patient advocates, researchers and global clinical experts and by September 2020, established the ICD-10 code (U09) and ICD-11 code (RA02) for post COVID-19 condition.
While we continue to understand more about the acute phase of COVID-19, there remains limited information regarding long-term outcomes. The Institute for Health Metrics and Evaluation (IHME) estimated that by the end of 2021, 3.92 billion individuals had been infected with SARS-CoV-2 and that 3.7% (144.7 million) developed post COVID-19 condition as defined by the WHO clinical case definition with 15.1% (22 million) having persistent symptoms at 12 months after infection onset. Persistent symptoms, complications, and sequelae of COVID-19 such as pulmonary, cardiovascular, neurological, and physical effects have been increasingly reported globally; yet the underlying aetiology, prevalence, and risk factors are still not clearly understood.
As the COVID-19 pandemic continues, WHO remains committed to learning more about the medium and long-term outcomes for people with post COVID-19 condition by further characterizing the condition, assessment and evaluation of clinical management approaches, rehabilitation, and models of care.
WHO developed a clinical case definition of post COVID-19 condition by Delphi methodology that includes 12 domains, available for use in all settings. This first version was developed by patients, researchers, and others, representing all WHO regions, with the understanding that the definition may change as new evidence emerges and our understanding of the consequences of COVID-19 continues to evolve.
Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS- CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms that last for at least 2 months and cannot be explained by an alternative diagnosis. Common symptoms include fatigue, shortness of breath, cognitive dysfunction but also others which generally have an impact on everyday functioning. Symptoms may be new onset, following initial recovery from an acute COVID-19 episode or persist from the initial illness. Symptoms may also fluctuate or relapse over time.
A separate clinical case definition for children and adolescents has also been produced, through a process of expert consensus, which recognizes the unique health needs and challenges of this group of people.
Living Guidance for Clinical Management of COVID-19: Rehabilitation of adults with post COVID-19 condition
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform, and is updated regularly as new evidence emerges. No further updates to the previous existing recommendations were made in this latest version.
This updated (fifth) version contains 16 new recommendations for the rehabilitation of adults with post COVID-19 condition (see Chapter 24), which includes:
conditional recommendations for
Guidelines regarding the use of drugs to treat COVID-19 are included in a separate WHO document, Therapeutics and COVID-19: living guideline, that can via an online platform and in pdf format (or click ‘PDF’ in top right corner of online platform).
Guidelines regarding the use of drugs to prevent COVID-19 are included in a separate document, WHO Living guideline: Drugs to prevent COVID-19, that can be accessed via an online platform and in pdf format (or click ‘PDF’ in top right corner of online platform).
To view previous (now outdated) versions of this guideline, please see the links below:
Publications
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with...
WHO has developed a clinical case definition of post COVID-19 condition by Delphi methodology that includes 12 domains, available for use in all settings....
People who are critically unwell with COVID-19 are likely to have rehabilitation needs during and after their acute illness. In many individuals recovering...
On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and...
Global Clinical Data Platform for COVID-19
Global understanding of the natural history of COVID-19, its clinical features, prognostic factors and outcomes remains incomplete. In response, the WHO has created a global clinical platform of patient-level anonymized clinical data. The Platform is a secure, limited-access, password-protected platform hosted on REDCap. The objectives of the Platform are to:
|
WHO developed four clinical characterization case report forms (CRF) to standardize data collection of clinical features of COVID-19 among hospitalized patients and among patients experiencing post-COVID-19 condition. The 4 different CRFs include Core, Multi-Inflammatory Syndrome in children (MIS-C) and Post-COVID-19 condition.
The post COVID-19 CRF is a tool that can be used by Member States to document the mid- and long-term sequelae of COVID-19. Uniformity in the follow up of patients will ensure that mid- and long-term clinical and rehabilitation needs are identified, and patients are provided the care they need. The CRF is a tool for gathering standardized information regarding post COVID-19 sequelae through the WHO Global Clinical Platform. Such data collation and its analysis would improve national and global knowledge of the consequences of COVID-19, inform further public health responses and prepare for large investigational studies.
WHO encourages Member States and researchers to contribute data through the Post COVID-19 Condition Case Report Form on the WHO Global Clinical Data Platform for COVID-19.
Resources for health workers
Resources for individuals with post COVID-19 condition and their families
News